The Next platform will analyze clinical data from mBC patients treated in certain centers and notify clinicians when ESR1 testing is missing at disease progression.
Tempus AI,...
Harbour BioMed, a global biopharmaceutical company committed to the discovery, development and commercialization of novel antibody therapeutics focusing on immunology and oncology, and Insilico...
Document Summarizer is part of a suite of industry-leading tools from MasterControl assisting in streamlining quality management processes for life sciences and regulated industries.
MasterControl,...
Latent Labs, the company building AI foundation models to make biology programmable, emerged from stealth with $50M in total funding to accelerate their progress...
Tempus AI, Inc., a technology company leading the adoption of AI to advance precision medicine and patient care, announced a new collaboration with the...
Lindus Health, the "anti-CRO" running radically faster, more reliable clinical trials, has announced their collaboration with the Clinical Data Interchange Standards Consortium (CDISC), to accelerate...
Alliance to add focus for Large Quantitative Models (LQMs) which are the new frontier in AI with applications in biopharma, energy and other sectors
SandboxAQ...
Capgemini announced a new generative AI-driven methodology for protein engineering that uses a specialized protein large language model (pLLM) to predict the most effective...
With the goal of streamlining industry-wide clinical trial recruitment and improving patient outcomes, myTomorrows unveils its next major AI-powered technological advancement.
myTomorrows, a global health...
Inspire, the leading patient network and real-world evidence solutions provider, announced the launch of Patient Voice AI, a groundbreaking product designed to revolutionize how...